Meanwhile, iron deficiency anemia, blunted erythropoietin synthesis/response, and guideline-recommended treatments are assumed to be the most significant underlying factors responsible for the inception and exacerbation of anemia in HF patients [26]. This evidence concerns the gene EPO and Iron deficiency anemia.